Search results
Results From The WOW.Com Content Network
Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, [3] is an Indian multinational pharmaceutical company headquartered in Ahmedabad, which is primarily engaged in the manufacturing of generic drugs.
Zydus Lifesciences is launching a proof-of-concept Phase 2a clinical trial to evaluate the safety and efficacy of desidustat in people with sickle cell disease (SCD). The study is the result of a collaboration with the Indian Council of Medical Research (ICMR) [ 18 ]
Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company headquartered in HITEC City, Hyderabad.The company manufactures generic pharmaceuticals and active pharmaceutical ingredients.
India's Zydus Lifesciences is aiming to launch its first new drug in the United States by early 2026, looking to tap into the multi-billion dollar market for treating a type of liver disease ...
Zydus Lifesciences: Ahmedabad ₹ 499 billion (US$6.0 billion) [32] 3: Lupin: Ahmedabad ₹ 299.67 billion (US$3.6 billion) [33] 4: Alembic Pharmaceuticals: Vadodara ₹ 108 billion (US$1.3 billion) [34] 5: Eris Lifesciences: Ahmedabad ₹ 100 billion (US$1.2 billion) [35] 6: Dishman Carbogen Amcis: Ahmedabad ₹ 80 billion (US$960 million) [36]
Monday, Integra LifeSciences Holdings Corporation (NASDAQ:IART) reported first-quarter revenues of $368.9 million, down 3.1% Y/Y on a reported basis and 2.5% on an organic basis, beating the ...
Markets seesawed on the first trading day of 2025 as investors grappled with big questions ahead of a change of power in Washington. U.S. stocks jumped in early trading, then zigzagged throughout ...
Pankaj Ramanbhai Patel (born 16 March 1953) is an Indian billionaire businessman, and the chairman of Zydus Lifesciences, the fifth largest pharmaceutical company in India. In October 2024, Patel was ranked 24th on the Forbes list of India’s 100 richest tycoons, with a net worth of $10.2 billion.